Cytosorbents (CTSO) Work In Process (2023 - 2026)

Cytosorbents (CTSO) has 4 years of Work In Process data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 99.66% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 99.66% YoY), and the FY2025 full-year result was $1.0 million, up 101.59% from the prior year.
• Work In Process for Q1 2026 stood at $1.2 million, up from $1.0 million in the prior quarter.
• Across five years, Work In Process topped out at $1.2 million in Q1 2026 and bottomed at $503000.0 in Q4 2024.
• The 4-year median for Work In Process is $838871.0 (2023), against an average of $875775.3.
• The widest annual swing landed in 2024, when Work In Process tumbled 40.04%; it then jumped 101.59% in 2025.
• A 4-year view of Work In Process shows it stood at $838871.0 in 2023, then sank by 40.04% to $503000.0 in 2024, then soared by 101.59% to $1.0 million in 2025, then gained by 22.39% to $1.2 million in 2026.
• The last three Work In Process figures came in at $1.2 million (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison